Home / Guides / By state / Tirzepatide in Maryland

Maryland rules, read closely.

Tirzepatide online in Maryland: providers, prices and rules

Medically reviewed by the NexLife clinical team, led by Adam Kennah, MD · Updated

NexLife publishes this guide and is one of the programs in it. Every program, ours included, faces the same tests, and every price links to its source.

Maryland Medicaid covers Zepbound only for sleep apnea, not weight loss; online programs charge $139 to $399 monthly for compounded tirzepatide (checked October 15, 2026). NexLife charges $139 a month on its 12-month plan, or $169 month to month, whatever the dose.

$139/mo on 12 months, every dosePrice Match Guarantee†

  • Maryland Medicaid covers Zepbound for sleep apnea, not weight loss
  • A 2026 law lets Medicaid add obesity care from 2027
  • Nonresident pharmacies must name a Maryland-licensed pharmacist
Published by NexLifeLegitScript-certifiedUpdated Medically reviewed by the NexLife clinical team, led by Adam Kennah, MD (NPI 1144260043)
NexLifeOne price, every dose

$139/mo on a 12-month plan, all-inclusive, same price at every dose

Or $169/mo month to month

Check my eligibility

About 3 minutes of health questions · No insurance needed · Not prescribed? No charge for medication

See all 4 plans and what a year costs
Compounded tirzepatide, all in, the same price at every dose
PlanPer month12 months at this rate
12-month Lowest monthly price$139$1,668
6-month$149$1,788
3-month$159$1,908
Month to month$169$2,028

Month to month costs $360 more over 12 months than the 12-month plan. Plans renew until you cancel. Longer plans bill the way you choose at checkout.

Price Match Guarantee†. Paying less elsewhere? We match your regular monthly price. How it works

Call (949) 818-8000Text us

4.8 out of 5 on Trustpilot, 403 reviewsLegitScript-certified

Compounded, not FDA-approved. A licensed provider prescribes it only when it offers a significant difference for you. The vial shown is an illustration.

  • Licensed U.S. providers
  • LegitScript certified
  • Free expedited shipping
  • HSA, FSA, Affirm, Klarna, Afterpay
  • 24/7 support, real people
  • Filled by Absolute Pharmacy (Lutz, FL) or Boudreaux’s New Drug Store (Lake Charles, LA)

All 10 at a glance, A to Z

Listed A to Z, each with its own published price; NexLife publishes this guide and doesn’t rank itself.

Comparing programs nationally? See the best tirzepatide providers online, compared side by side with prices and check dates.

  1. Tell us about you About 3 minutes of health questions
  2. A licensed provider decides You’re prescribed only if it’s right for you
  3. Your partner pharmacy ships Usually within 1 to 2 business days, free

Key takeaways

  • Medicaid pays for Zepbound only for sleep apnea. Maryland’s form asks for moderate to severe sleep apnea, a BMI of 30 or more and a sleep specialist’s input; weight loss alone doesn’t qualify (checked October 25, 2026).
  • 2027 could change that. A 2026 law, SB 496, lets Maryland Medicaid cover comprehensive obesity treatment starting January 1, 2027. It doesn’t require it, so the Maryland Department of Health decides.
  • The evaluation comes first. Maryland’s Board of Physicians requires a clinical evaluation suited to you before a telehealth prescription and sets its own rules for how it can happen (COMAR 10.32.05); your provider follows them.
  • Out-of-state pharmacies answer to Maryland. A nonresident pharmacy needs a Maryland Board of Pharmacy permit and a Maryland-licensed pharmacist designated as responsible for patients here (Health Occupations § 12-403).
  • NexLife’s price doesn’t move with your dose. It’s $139 a month on its 12-month plan or $169 month to month, and provider care, a nutrition plan and free shipping come with it.

Maryland rules

Maryland’s rules for online tirzepatide

Maryland Medicaid covers Zepbound only for sleep apnea, not weight loss alone, and may add obesity coverage from January 1, 2027. The state employee plan excludes weight-loss drugs. A prescriber must evaluate you first, and an out-of-state pharmacy needs a Maryland permit and a Maryland-licensed pharmacist.

Medicaid, now and from 2027. Maryland Medicaid covers Zepbound with prior authorization for moderate to severe obstructive sleep apnea, and Wegovy when a patient has heart disease or MASH (a liver disease), but neither for weight loss alone (form dated December 2025, checked October 25, 2026). SB 496, Chapter 866 of 2026, lets the program offer comprehensive obesity treatment coverage beginning January 1, 2027, if the Department of Health elects to. It became law without the governor’s signature on May 31, 2026 and took effect October 1, 2026.

State employees, 2026 plan year. The State of Maryland’s Health Benefits Guide lists weight-loss drugs among the medications its prescription plan excludes. Diabetes GLP-1s are covered with prior authorization.

The evaluation, COMAR 10.32.05.05 and .06. Under the Board of Physicians’ telehealth rules, a practitioner must do a clinical evaluation that fits you and your condition before treating you or prescribing by telehealth, and the rules set how that evaluation can happen (checked October 25, 2026). Your provider follows them, and the standard of care applies.

The pharmacy, Health Occupations § 12-403. A pharmacy outside Maryland needs a Maryland Board of Pharmacy permit and a pharmacist on staff who holds a Maryland license and is designated as responsible for patients in the state. Its permit application includes an inspection report from the past two years, plus a sterile compounding inspection report if it compounds injections. Look up a Maryland pharmacy permit.

In the law’s words: “A nonresident pharmacy shall: (1) Hold a pharmacy permit issued by the Board; and (2) Have a pharmacist on staff who is: (i) Licensed by the Board; and (ii) Designated as the pharmacist responsible for providing pharmaceutical services to patients in the State.” (Maryland Code, Health Occupations § 12-403(e))

Porch weather. Baltimore’s average July high is 88.8°F (NOAA 1991–2020 normals, BWI), and a box left out can warm fast on a humid afternoon or freeze on a January morning. Bring deliveries inside right away.

Who it touches. 33.1% of Maryland adults had obesity in 2025, and 38.4% of those aged 40 to 59 (CDC BRFSS, published September 2026). Maryland’s attorney general joined the February 2025 letter from 38 states and territories urging the FDA to act against counterfeit and unsafe GLP-1 sellers.

Maryland’s tirzepatide rules, and what each means for you (read October 21 to 25, 2026)
Maryland ruleWhat it means for you
Medicaid prior authorization, December 2025Zepbound for moderate to severe sleep apnea, not weight loss alone
SB 496, Chapter 866 of 2026Medicaid may add obesity treatment from January 1, 2027; it isn’t required to
2026 Health Benefits GuideState employees: weight-loss drugs are excluded
COMAR 10.32.05.05 and .06An evaluation suited to you comes first
Health Occupations § 12-403An out-of-state pharmacy needs a Maryland permit and a Maryland-licensed pharmacist

What would you pay with NexLife?

Tap where you are now. We’ll show your NexLife price next to it, or tell you we’ll match it.

Pick one above to see your price.

Check my eligibility
Not today?

Prices from each provider’s own site, checked October 15, 2026. Brand-name and compounded medications are different products: compounded medications aren’t FDA-approved, and a provider prescribes one only when it offers a significant difference for you. Price Match Guarantee† terms apply.

The NexLife Price Match Guarantee†

Keep your price.
Upgrade your care.

Already on compounded tirzepatide or semaglutide? Pay less with another licensed U.S. telehealth provider or clinic, and we match your regular monthly price for as long as your plan stays active.† Plus a provider who follows your dose, a nutrition plan, a coaching call and real people 24/7.

  1. 1Send a receipt from the last 60 days
  2. 2A NexLife provider reviews your prescription
  3. 3Pay your matched price, at every dose
Switch and keep my price

Locked while your plan is activeSame price at every doseNo membership fee

†Terms: see the Price Match Guarantee† details below. Compounded medications aren’t FDA-approved; a provider prescribes one only when it offers a significant difference for you.

Fair questions

Will my price go up with my dose?
No. You pay the same at every dose.
What if I’m not prescribed?
You aren’t charged for medication.
Can I cancel?
Yes, by email or phone, with 30 days’ notice. Plans renew until you cancel; our cancellation policy has the details.
Do I need insurance?
No. Pay with an HSA or FSA card, or with Affirm, Klarna or Afterpay at checkout.

Maryland prices

Maryland prices: coverage versus cash

Unless sleep apnea qualifies you for Medicaid coverage, most Maryland routes are cash routes. Zepbound is $299 to $449 a month at LillyDirect, by dose, and compounded tirzepatide, which isn’t FDA-approved, runs $139 to $399 online. At NexLife it’s $139 a month on the 12-month plan or $169 month to month.

How Marylanders can pay for tirzepatide (prices checked October 15, 2026; coverage read October 25, 2026)
RouteWhat it costsThe catch
Maryland MedicaidZepbound covered for sleep apnea, with prior authorizationWeight loss alone doesn’t qualify
State of Maryland employee planWeight-loss drugs excludedDiabetes GLP-1s need prior authorization
Brand-name Zepbound (LillyDirect)$299 to start, $399 at 5 mg, $449 at 7.5 mg or higherFDA-approved; the medication only
Compounded tirzepatide in our index$139 to $399 a month; median $23714 online programs; not FDA-approved
Compounded tirzepatide through NexLife$139 a month (12-month plan) or $169 (month to month)No membership fee; care, coaching and shipping included

Two compounded prices set the low end of our index: PreventiveMD at $139 month to month, with no longer plans listed, and Mochi Health, which charges $169 at its lowest dose and more as the dose rises. Each of the 10 programs listed at the top of this page has a full, sourced review on our best tirzepatide providers online page.

Maryland Medicaid

The sleep apnea route to Zepbound on Maryland Medicaid

A prescriber documents five things on Maryland’s form (December 2025): a sleep study showing moderate to severe obstructive sleep apnea, a BMI of 30 or more from the last 90 days, a sleep specialist or similar expert involved, a 6-month weight management try without weight loss and no other GLP-1, and yearly proof after 12 months.

  1. A sleep study, in a lab or at home, showing moderate to severe obstructive sleep apnea: at least 15 breathing events an hour.
  2. A BMI of 30 or more, measured within the last 90 days.
  3. A prescription from, or in consultation with, a sleep specialist, a pulmonologist or another provider experienced in sleep apnea.
  4. Your prescriber’s signed statement that you tried weight management in the past 6 months without losing weight, and that you aren’t taking another GLP-1.
  5. After the first 12 months, fresh documentation of moderate to severe sleep apnea every year.

Without sleep apnea, Maryland Medicaid won’t cover Zepbound for weight loss today. SB 496 lets the state add obesity treatment from January 1, 2027, but leaves the choice to the Department of Health.

State employees

What does the State of Maryland plan cover for tirzepatide?

Not weight loss. The 2026 Health Benefits Guide lists weight-loss drugs among its exclusions, so Zepbound for weight loss isn’t covered. Mounjaro, tirzepatide’s brand for type 2 diabetes, is a GIP/GLP-1 drug, and the guide puts “Diabetic GLP-1s/GIPs” on its prior authorization list (pages 25 and 26, checked October 25, 2026). For weight loss, state workers pay cash.

Who decides. MedImpact Healthcare Systems runs the plan’s prescription benefit. Its prior authorization list can change during the year. The current list is posted at mymdbenefits.com, and MedImpact answers member questions at 1-844-348-8508.

Diabetes support. For members with diabetes, the plan’s MedEmpower Fuel benefit adds a glucometer, test strips and coaching.

Two medications.
One flat price at every dose.

No membership fee. Provider care, a nutrition plan, coaching and shipping are included. Paying less with another licensed provider? We match your regular monthly price.†

GIP + GLP-1

12-month plan $139/mo

Tirzepatide

Weekly and dual-action. Care, coaching and shipping included. On a 12-month plan; $169/mo month to month.

Check my eligibility

Compounded, not FDA-approved · Not prescribed? No charge for medication

GLP-1

12-month plan $119/mo

Semaglutide

Weekly GLP-1. Care, coaching and shipping included. On a 12-month plan; $139/mo month to month.

Check my eligibility

Compounded, not FDA-approved · Not prescribed? No charge for medication

  1. Tell us about you About 3 minutes of health questions
  2. A licensed provider decides You’re prescribed only if it’s right for you
  3. Your partner pharmacy ships Usually within 1 to 2 business days, free

Compounded, not FDA-approved. A licensed provider prescribes it only when it offers a significant difference for you. Vials shown are illustrations; your pharmacy’s label will look different. Every plan and price · Price Match Guarantee† terms

Tirzepatide in Maryland: your questions

Does Maryland Medicaid cover Zepbound?

Only for moderate to severe obstructive sleep apnea, with prior authorization. Maryland’s form asks for a sleep study showing at least 15 events an hour, a BMI of 30 or more and a sleep specialist or pulmonologist involved (December 2025 form, checked October 25, 2026). Zepbound for weight loss alone isn’t covered.

Will Maryland Medicaid cover weight-loss drugs in 2027?

It may. SB 496, now Chapter 866 of 2026, lets Maryland Medicaid provide comprehensive obesity treatment coverage starting January 1, 2027, and the Department of Health must tell members if it chooses to. The law doesn’t require that coverage.

How does a doctor ask Maryland Medicaid to cover Zepbound?

With the state’s Wegovy or Zepbound prior authorization form (MDH 12/2025), faxed to (866) 440-9345; questions go to (833) 325-0105. The form needs your sleep study date and AHI score, and a BMI from the last 90 days. Your doctor states you’ll pair the drug with a reduced-calorie diet and exercise. Incomplete forms aren’t reviewed (checked October 25, 2026).

What does Maryland require before an online tirzepatide prescription?

A clinical evaluation that suits you and your condition. The Board of Physicians’ rules set how it can happen and what can’t be the sole basis for treating or prescribing (COMAR 10.32.05.05 and .06, checked October 25, 2026). Your provider follows them.

Can my provider evaluate me online for tirzepatide in Maryland?

Yes. Under COMAR 10.32.05.05, a practitioner may evaluate you by telehealth before prescribing, as long as the evaluation fits you and your condition (checked October 25, 2026). The rule also works the other way: when more care is clinically appropriate for you, the practitioner must provide it or refer you.

How much does compounded tirzepatide cost in Maryland?

Online, the 14 tirzepatide programs our GLP-1 price index tracks charge between $139 and $399 a month, with $237 in the middle (checked October 15, 2026). Brand-name Zepbound costs $299 to $449 a month at LillyDirect, plus whatever your prescriber charges. NexLife’s 12-month plan is $139 a month, and month to month it’s $169, with no membership fee.

Does the Maryland state employee plan cover Zepbound for weight loss?

No. The State of Maryland’s 2026 Health Benefits Guide lists weight-loss drugs among the medications its prescription plan excludes, while GLP-1s for diabetes need prior authorization (checked October 25, 2026).

What license does an out-of-state pharmacy need to ship to Maryland?

A Maryland Board of Pharmacy permit, plus a pharmacist on staff who holds a Maryland license and is designated as responsible for Maryland patients (Health Occupations § 12-403). The Board’s permit lookup shows a pharmacy’s status. If you order through NexLife, care is offered only where its affiliated providers are licensed.

Is compounded tirzepatide legal in Maryland?

Yes, with a prescription, if the pharmacy follows Maryland’s rules. An out-of-state pharmacy needs a Board of Pharmacy permit. For compounded sterile preparations, such as tirzepatide injections, it must also meet USP standards and COMAR 10.34.19, Maryland’s sterile compounding chapter (COMAR 10.34.37.04, checked October 25, 2026). Compounded tirzepatide isn’t FDA-approved.

How can I tell a pharmacy may ship tirzepatide to Maryland?

Look for three things. It holds a Maryland Board of Pharmacy permit, which the Board’s lookup shows. It names a pharmacist licensed in Maryland as responsible for patients here. And it prints a toll-free number for reaching a pharmacist on every container it sends (COMAR 10.34.37.04, checked October 25, 2026).

What if my tirzepatide arrives warm or frozen in Maryland?

Don’t use it. Baltimore’s July afternoons average 88.8°F (NOAA normals), and a January porch can freeze a box, so bring deliveries in as soon as they arrive. Call or text (949) 818-8000 and NexLife will get in touch with the pharmacy for you.

Important safety information

Compounded tirzepatide and semaglutide are not FDA-approved, and the FDA hasn’t reviewed them for safety, effectiveness or quality. A provider prescribes them only when they offer a significant difference for you compared with an FDA-approved product. Both medicines may cause thyroid tumors, including cancer: don’t use either if you or a family member has had medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2).

Read the full safety information

In studies with rodents, both medicines caused thyroid tumors; it isn’t known whether they cause them in people. Tell your provider if you notice a lump or swelling in your neck, hoarseness, trouble swallowing or shortness of breath. Serious side effects can include inflammation of the pancreas (pancreatitis), gallbladder problems, low blood sugar (especially with insulin or sulfonylureas), kidney problems from dehydration, severe stomach problems, serious allergic reactions, vision changes in people with type 2 diabetes, and a faster heart rate. Tell your care team before any surgery or procedure that uses anesthesia or deep sedation. Don’t combine either medicine with other GLP-1 medicines.

Tirzepatide can make birth control pills less effective: switch to a non-oral method, or add a barrier method such as condoms, for 4 weeks after you start and for 4 weeks after each dose increase. Both medicines may harm an unborn baby. Semaglutide should be stopped at least 2 months before a planned pregnancy. Tell your provider right away if you’re pregnant, planning to be, or breastfeeding.

This is a summary, not the complete safety information. Read the full Prescribing Information for FDA-approved tirzepatide (Zepbound) and semaglutide (Wegovy), and talk with your provider. You can report side effects to the FDA at 1-800-FDA-1088 or fda.gov/medwatch.

† NexLife Price Match Guarantee: for new NexLife members switching from a licensed U.S. telehealth provider or clinic with an active prescription for compounded tirzepatide or semaglutide. We match your regular all-in monthly price there (medication plus any required membership, program or visit fee, on a month-to-month plan); first-month offers, coupons, referral credits and prepaid multi-month rates aren’t matched. Proof from the last 60 days required. A licensed provider must determine that treatment is right for you. Not open to people with Medicare, Medicaid or TRICARE coverage. Full terms.

About NexLife. NexLife is a telehealth and care-coordination platform. Care is delivered through affiliated, physician-owned medical groups, and licensed providers decide whether treatment is right for you. NexLife doesn’t make or compound medication: state-licensed partner pharmacies fill each prescription, and we coordinate the rest. NexLife is offered only in states where our affiliated providers are licensed.

Who checked this page

Adam Kennah, MDMedical Director, NexLife · Board-certified in emergency medicine (American Board of Emergency Medicine) · NPI 1144260043

Leads the NexLife clinical team, which medically reviews each of NexLife’s guides, including this one.

NexLife editorial teamResearch and pricing

Prices checked October 15, 2026; Maryland rules checked October 21 through 25, 2026.

  • How we checked. Prices come from each company’s own site, checked October 15, 2026; state facts from the agencies and sources listed below. “All in” means medication plus any membership or program fee you must pay. Brand-name Zepbound is listed separately from compounded tirzepatide.
  • Every fact, sourced. Each price and rule links to the page it comes from.
  • How we make money. NexLife is a telehealth and care-coordination platform. We earn revenue when people join NexLife.
  • Corrections, fast. See something wrong or out of date? Email care@nexlife.us and we’ll fix it.

Paying less elsewhere? We match it.†

A price that stays put as your dose rises.

Compounded tirzepatide through NexLife costs $139 a month if you choose 12 months, or $169 if you go month to month. A licensed provider evaluates you before anything is prescribed.

Check my eligibilityPrefer semaglutide? $119/mo on 12 months
Call (949) 818-8000Text us

4.8 out of 5 on Trustpilot · Medical director Adam Kennah, MD (NPI 1144260043) · LegitScript-certified

Compounded medications aren’t FDA-approved. A provider prescribes one only when it offers a significant difference for you.

  1. 1
    Tell us about you

    Start online with your health history.

  2. 2
    A licensed provider decides

    A licensed provider reviews your health history and decides whether treatment is right for you, following your state’s rules. You’re prescribed only if it is.

  3. 3
    We ship it, then stay with you

    Our partner pharmacy usually ships within 1 to 2 business days. Free shipping, and questions come to us 24/7, never to the pharmacy.

Sources

  1. KFF: Medicaid coverage of GLP-1s for obesity, January 2026. Read October 19, 2026.
  2. Maryland Department of Health: Wegovy or Zepbound prior authorization form (December 2025). Read October 19, 2026; rechecked October 25, 2026.
  3. State of Maryland: 2026 Health Benefits Guide (employees and retirees). Read October 19, 2026; rechecked October 25, 2026.
  4. COMAR 10.34.37: pharmacy permit holder and nonresident pharmacy operations (Maryland Board of Pharmacy). Read October 19, 2026; checked again October 25, 2026.
  5. Maryland Board of Pharmacy. Read October 19, 2026.
  6. CDC: Adult Obesity Prevalence Maps, 2025. Read October 19, 2026.
  7. Md. Code, Health Occupations § 12-403: nonresident pharmacies. Read October 19, 2026.
  8. PreventiveMD: compounded tirzepatide prices. Checked October 15, 2026.
  9. Mochi Health: compounded tirzepatide prices. Checked October 15, 2026.
  10. Rx.com: compounded tirzepatide prices. Checked October 15, 2026.
  11. Noom: compounded tirzepatide prices. Checked October 15, 2026.
  12. Remedy Meds: compounded tirzepatide prices. Checked October 15, 2026.
  13. Ondra Health: compounded tirzepatide prices. Checked October 15, 2026.
  14. NexLife: compounded tirzepatide plans. Checked October 15, 2026.
  15. LillyDirect: Zepbound self-pay pricing. Checked October 15, 2026.
  16. Ro: membership and medication pricing. Checked October 15, 2026.
  17. Hims: Zepbound KwikPen and membership. Checked October 15, 2026.
  18. FDA: Compounding and the FDA, questions and answers.
  19. Zepbound (tirzepatide) Prescribing Information, Eli Lilly.
  20. Hims: Wegovy pill and pen, with membership. Checked October 15, 2026.
  21. Embody: compounded tirzepatide, one-month supply. Checked October 15, 2026.
  22. Embody: compounded semaglutide, one-month supply. Checked October 15, 2026.
  23. Maryland General Assembly: SB 496 (2026), Chapter 866, Medicaid coverage for the treatment of obesity. Checked October 25, 2026.
  24. COMAR 10.32.05.05: telehealth patient evaluation (Maryland Board of Physicians). Checked October 25, 2026.
  25. COMAR 10.32.05.06: standards related to telehealth. Checked October 25, 2026.
  26. Maryland Board of Pharmacy: nonresident pharmacy application (inspection reports). Seen October 21, 2026.
  27. Maryland Board of Pharmacy: license and permit lookup. Seen October 21, 2026.
  28. Bipartisan letter from 38 attorneys general on counterfeit GLP-1 drugs (Tennessee Attorney General’s office, February 20, 2025). Seen October 21, 2026.
  29. BWI Marshall Airport monthly highs, 1991–2020 climate normals (NOAA). Seen October 21, 2026.